Abstract
Background/Aim: Prostate cancer patients undergoing radiotherapy (RT) may experience distress. This study evaluated the course of distress during RT. Patients and Methods: Four distress characteristics were analyzed for change of distress in 136 patients irradiated for prostate cancer, including age, Karnofsky performance score, intent of RT, and previous RT. Results: Mean distress scores were 4.3 (±2.9) at baseline and 4.2 (±2.7) at the end of RT. Associations with increased distress were found for KPS >80 (p<0.001) and curative intent RT (p=0.072). When evaluating increased distress as binary variable (yes vs. no), KPS >80 was significant on univariable (p<0.001) and multivariable (p=0.016) analyses. In patients with baseline scores ≤5 points, KPS >80 was associated with mean change of distress (p=0.009) and increased distress (p=0.029). Conclusion: Many patients receiving RT for prostate cancer do not experience increased distress during their treatment course. Patients at higher risk of increased distress may require early psychological assistance.
Prostate cancer represents one of the most common cancer types worldwide, particularly in Western countries (1). Many of these patients are treated with external beam radiotherapy (EBRT) with or without a brachytherapy boost (2). The quality of life of patients assigned to radiotherapy (RT) may be impaired by psychological distress. Such distress may be a consequence of fear of treatment-related acute and late toxicities or exposure to complex technology and radiation (3-6). In a previous study, the prevalence of worry and fears was 25% and 27%, respectively (7). Uncertainty exists regarding the process of distress during the weeks of radiation treatment. On one hand, it is conceivable that the distress increases in case of acute toxicity. On the other hand, the patients may get used to the procedure and the technology of irradiation, which likely would lead to a reduction of distress. Or both aspects may be balanced, and no significant change in distress will occur. In a previous study of 200 patients irradiated for different malignancies, the mean distress score decreased in the majority of patients including those with prostate cancer (8). The present study focused particularly on patients irradiated for prostate cancer to characterize changes in distress during the course of RT and identify specific risk factors of increased distress for this patient group.
Patients and Methods
One-hundred-and-thirty-six patients irradiated for prostate cancer at two centers in Northern Germany between November 2021 and November 2022 were included in this retrospective study. The study received initial approval from the ethics committee at the University of Lubeck (2022-486). Distress was measured with the Distress Thermometer of the National Comprehensive Cancer Network (NCCN), which was completed by the patients prior to (baseline) and on the last day of their radiation therapy (9). Distress scores ranged between 0 (no distress) and 10 (maximum distress) points. Four characteristics (Table I) were analyzed for correlation with the change of distress scores during the time of the RT series. For calculation of the change of distress, baseline distress scores were subtracted from the scores indicated by the patients on the last day of RT. Characteristics included age (≤64 vs. 65-79 vs. ≥80 years, Karnofsky performance score (≤80 vs. >80), intent of RT (curative vs. palliative), and experience of prior RT (no vs. yes).
Mean values and standard deviations of the changes were calculated. Associations between characteristics and mean changes of distress scores were statistically analyzed with the exact Wilcoxon two-sample test (two subgroups) and the Kruskal-Wallis test (three or more subgroups). In addition, rates of improvement (score decreased by ≥2 points), no change (difference −1 to +1 point), and deterioration (score increased by ≥2 points) of distress are given. Associations of the four characteristics with these outcomes were also performed with the exact Wilcoxon two-sample test and the Kruskal-Wallis test. For additional evaluations regarding increase of distress, the binary variable “yes vs. no” was used. Corresponding statistical analyses were performed with the Chi-square test (univariable analyses) and a logistic regression (multivariable analyses). Separate subgroup analyses were performed in patients with baseline distress scores ≤5.
In all analyses described above, p-values <0.05 were regarded significant and p-values <0.10 indicating a trend.
Results
In the entire series, mean distress scores were 4.3 (±2.9) at baseline and 4.2 (±2.7) at the last day of RT, and the mean change was −0.1 (±2.8) points. A significant association with increased distress was found for KPS >80 (p<0.001, Table II), and curative intent of treatment showed a trend (p=0.072). Similar results were found when all outcomes (improvement, no change, or deterioration) of distress scores were considered (Table III).
When evaluating increase of distress as a binary variable (yes vs. no), KPS >80 was significantly associated with increased distress in both the univariable (p<0.001, Table III) and the multivariable (p=0.016, Table IV) analyses. In addition, curative intent of treatment showed a trend on univariable analysis (p=0.072, Table III).
In the subgroup analyses of patients with baseline scores ≤5 points, KPS >80 was significantly associated with mean change of distress scores (p=0.009, Table V), when considering all outcomes (improvement, no change, or deterioration) of distress (p=0.011, Table VI), and increased distress during the course of RT (p=0.029, Table VI).
Discussion
In a previous retrospective study of 102 patients irradiated for prostate cancer, the patients were asked to rate the six emotional problems included in the Distress Thermometer of the NCCN, namely worry, fears, sadness, depression, nervousness, and loss of interest in usual activities (7, 9). The prevalence was the highest for worry (25%) and fears (27%), followed by nervousness (18%), sadness (11%), depression (11%), and loss of interest (5%) (7). Only very few other studies investigated specific emotional problems in prostate cancer patients. A retrospective study evaluated the prevalence of anxiety and depression in 861 men who received RT or radical surgery (10). Depression and anxiety were reported by 17% and 25% of the patients, respectively. However, the patients were not asked to report the emotional problems they had experienced immediately prior to their treatment but during the last seven years prior to that study. Therefore, these findings are of limited comparability with our previous study (7). In a secondary analysis of a randomized trial investigating the impact of nurse-led intervention of supportive care in patients with prostate cancer, pre-treatment (baseline) distress scores were evaluated using the NCCN Distress Thermometer (11). In that study, <20% of the patients reported distress scores of 4 or higher, which were considered indicating significant distress. These patients had a higher symptom burden, more unmet needs and concerns regarding their treatment, and a worse quality of life. The prevalence of <20% was in the range of emotional problems (5-27%) found in our previous study (7).
When summarizing the data regarding emotional distress prior to RT for prostate cancer, the prevalence at baseline was lower than that in patients undergoing RT for other malignant diseases (12-16). For example, the prevalence of specific emotional problems was 12-46% in patients irradiated for breast cancer, 11-47% in patients irradiated for head-and-neck cancers, 16-57% in patients irradiated for gynecological cancers, 11-47% in patients irradiated for rectal or anal cancer, and 23-63% in patients irradiated for malignant gliomas, respectively.
In contrast to these studies that evaluated the prevalence of distress, the present study investigated the course of distress during RT. The mean distress scores at baseline and at the end of RT were almost identical, suggesting that many patients irradiated for prostate cancer do not experience an increase of distress during their course of treatment. These results agree with the findings of our pilot study investigating the course of distress in 200 patients irradiated for any type of malignant disease (8). In the 22 patients with prostate cancer who were evaluable for the course of distress, the mean distress scores decreased by 0.5 (±2.3) points during RT. The pilot study found the primary tumor type to be associated with increased distress, but was not designed to identify risk factors for patients with a particular tumor type (8). This was a major goal of the present study, which has been successful in this regard. It shows that some groups of prostate cancer patients have a comparably high risk of increased distress, namely patients with a KPS >80 and those patients with curative intent of treatment. Moreover, in patients with a lower level of distress at baseline (≤5 points), a KPS >80 was also significantly associated with increased distress during RT. It is important to identify high-risk patients to provide early psychological assistance for them. The finding that also patients with lower baseline distress scores can experience worsening of distress during RT shows that it is important to offer psychological assistance to all patients at risk, irrespective if their baseline score. However, when following these suggestions, one should consider the retrospective design of this study including the potential risk of a hidden selection bias.
In summary, the mean distress scores at baseline and at the end of RT were almost identical. Thus, many patients irradiated for prostate cancer do not experience an increase of distress during their course of treatment. However, some groups of prostate cancer patients have a comparably higher risk of increased distress. The risk factors found in this study can help identify these patients, who should be offered early psychological assistance.
Acknowledgements
The study was funded by the European Regional Development Fund through the Interreg Deutschland-Danmark program (TreaT, 148-1.1-21).
Footnotes
Authors’ Contributions
S.J., C.D., N.Y.Y. and D.R. participated in the design of the study. The data were provided by C.D. and analyzed by a professional statistician supported by D.R. The article was written and approved by all Authors.
Conflicts of Interest
The Authors state that there are no conflicts of interest related to this study.
- Received June 22, 2023.
- Revision received July 17, 2023.
- Accepted July 18, 2023.
- Copyright © 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).